TY  - GEN
AU  - Avasarala,Jagannadha
TI  - Reader response: Alemtuzumab CARE-MS II 5-year follow-up: Efficacy and safety findings
SN  - 1526-632X
PY  - 2019///0813
KW  - Alemtuzumab
KW  - Antibodies, Monoclonal, Humanized
KW  - Humans
KW  - Multiple Sclerosis, Relapsing-Remitting
N1  - Publication Type: Journal Article; Comment
UR  - https://doi.org/10.1212/01.wnl.0000544324.09014.0e
ER  -